Bank targets hospitals, pharmaceutical firms, diagnostics and digital health as healthcare financing emerges as Nigeria’s next economic frontier
First City Monument Bank (FCMB) has committed ₦20 billion to finance private healthcare businesses across Nigeria, positioning healthcare as both a social necessity and an emerging investment opportunity as the country seeks to strengthen its health system and reduce dependence on imported medical products.
The bank announced the initiative during its inaugural Healthcare Summit in Lagos, describing the fund as part of a broader strategy to improve access to long-term financing for operators across Nigeria’s healthcare value chain.
According to FCMB, the Healthcare Fund will provide financing to hospitals, clinics, diagnostic centres, pharmaceutical manufacturers, pharmacies, maternity homes and other healthcare enterprises requiring capital for business expansion, medical equipment acquisition, infrastructure development, technology deployment and working capital.
The initiative aligns with the Federal Government’s Presidential Initiative for Unlocking the Healthcare Value Chain, which seeks to increase local production of medicines and medical devices to 70 per cent by 2030, while strengthening domestic healthcare infrastructure.
Speaking at the summit, FCMB Managing Director and Chief Executive Officer Yemisi Edun, whose address was delivered by Executive Director, Corporate Services and Service Management, Felicia Obozuwa, said access to affordable long-term finance remains one of the most critical requirements for transforming Nigeria’s healthcare sector.
“Healthcare is a social imperative and an economic priority. Building a strong healthcare system requires capital that is patient, affordable and long-term,” Edun said.
Beyond lending, FCMB disclosed that the programme will combine financing with advisory services, strategic partnerships and business support aimed at strengthening governance, financial reporting and operational capacity among healthcare enterprises.
The President of the Healthcare Federation of Nigeria (HFN), Njide Ndili, identified access to finance as one of the most significant constraints facing private healthcare providers.
She noted that previous financing initiatives implemented jointly with the PharmAccess Medical Credit Fund had demonstrated that healthcare businesses could maintain strong loan repayment records when financing was accompanied by technical support, capacity building and quality improvement programmes.
According to her, the Healthcare Federation intends to collaborate with FCMB in developing a framework for pre-qualifying healthcare businesses and preparing them to attract investment.
The federation currently represents more than 400 healthcare organisations and approximately 4,000 professionals across the sector.
Representing the Federal Government, the Minister of State for Health and Social Welfare, Dr Iziaq Salako, highlighted recent public investment in healthcare.
He disclosed that more than ₦339 billion has been disbursed through the Basic Healthcare Provision Fund over the past twelve years, including ₦235 billion within the last three years under the Health Sector Renewal Investment Initiative.
According to the minister, an additional ₦32.9 billion has recently been released to support more than 8,300 primary healthcare centres, with plans to expand coverage to approximately 13,000 facilities nationwide.
Salako called for stronger mobilisation of public and private investment while urging healthcare businesses to strengthen corporate governance, improve financial reporting and embrace blended financing structures capable of supporting sustainable growth.
The summit also examined investment opportunities across primary healthcare, diagnostics, pharmaceutical manufacturing, medical equipment, healthcare infrastructure and digital health.
BrandiQ Analysis
The significance of FCMB’s announcement extends well beyond banking. It signals that healthcare is gradually being repositioned from a social expenditure into a productive economic sector capable of attracting long-term investment capital.
For decades, healthcare financing in Nigeria has largely centred on government budgets, donor funding and out-of-pocket household expenditure.
Private investment has remained relatively limited, not because opportunities were absent, but because healthcare businesses often struggled to access long-term financing suited to their capital-intensive operations.
Hospitals, diagnostic centres and pharmaceutical manufacturers require substantial upfront investments in equipment, facilities, technology and skilled personnel – assets that generate returns over many years rather than within the short lending cycles preferred by commercial banks.
The emergence of dedicated healthcare financing therefore represents an important evolution in Nigeria’s financial landscape. Equally noteworthy is FCMB’s decision to combine lending with advisory support. This reflects growing recognition within development finance that capital alone rarely transforms businesses.
Healthcare enterprises also require stronger governance, financial management, operational efficiency and investment readiness to scale sustainably. The collaboration with the Healthcare Federation of Nigeria therefore moves beyond traditional lending towards building stronger healthcare institutions.
The Bigger Question: Is Nigeria Financing Healthcare – or Building a Healthcare Economy?
The more strategic question lies beyond the fund itself.
Is Nigeria merely financing healthcare delivery, or is it deliberately building a healthcare economy?
The distinction is significant. Financing hospitals addresses immediate healthcare needs.
Building a healthcare economy involves creating integrated value chains spanning pharmaceutical manufacturing, biotechnology, medical devices, diagnostics, digital health, health insurance, medical education, logistics, research and innovation.
Countries such as India, Singapore and South Korea transformed healthcare into major economic sectors by combining industrial policy, research investment, manufacturing capability and export competitiveness.
Nigeria’s ambition to achieve 70 per cent local production of medicines and medical devices by 2030 suggests movement in that direction.
However, achieving that target will require much more than financing.
Reliable electricity, research infrastructure, regulatory efficiency, pharmaceutical innovation, intellectual property protection, skilled health professionals and advanced manufacturing capacity will all be essential.
Healthcare industrialisation is therefore as much an economic policy challenge as it is a public health objective.
